[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Female Infertility Drugs Market - Global Outlook and Forecast 2022-2028

March 2022 | 79 pages | ID: F58BB120575CEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Female Infertility Drugs are usually prescribed to women as they're mostly used to help with ovulation problems.

This report contains market size and forecasts of Female Infertility Drugs in global, including the following market information:

Global Female Infertility Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Female Infertility Drugs Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Female Infertility Drugs companies in 2021 (%)

The global Female Infertility Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Parenteral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Female Infertility Drugs include Allergan Plc, Ferring BV, Merck KGaA, Novartis AG and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Female Infertility Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Female Infertility Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Female Infertility Drugs Market Segment Percentages, by Type, 2021 (%)
  • Parenteral
  • Oral
  • Others
Global Female Infertility Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Female Infertility Drugs Market Segment Percentages, by Application, 2021 (%)
  • Fertility Clinics
  • Hospitals
  • Cryobanks
Global Female Infertility Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Female Infertility Drugs Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Female Infertility Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Female Infertility Drugs revenues share in global market, 2021 (%)

Key companies Female Infertility Drugs sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Female Infertility Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Allergan Plc
  • Ferring BV
  • Merck KGaA
  • Novartis AG
  • Sanofi
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Female Infertility Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Female Infertility Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL FEMALE INFERTILITY DRUGS OVERALL MARKET SIZE

2.1 Global Female Infertility Drugs Market Size: 2021 VS 2028
2.2 Global Female Infertility Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Female Infertility Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Female Infertility Drugs Players in Global Market
3.2 Top Global Female Infertility Drugs Companies Ranked by Revenue
3.3 Global Female Infertility Drugs Revenue by Companies
3.4 Global Female Infertility Drugs Sales by Companies
3.5 Global Female Infertility Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Female Infertility Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Female Infertility Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Female Infertility Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Female Infertility Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Female Infertility Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Female Infertility Drugs Market Size Markets, 2021 & 2028
  4.1.2 Parenteral
  4.1.3 Oral
  4.1.4 Others
4.2 By Type - Global Female Infertility Drugs Revenue & Forecasts
  4.2.1 By Type - Global Female Infertility Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Female Infertility Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Female Infertility Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Female Infertility Drugs Sales & Forecasts
  4.3.1 By Type - Global Female Infertility Drugs Sales, 2017-2022
  4.3.2 By Type - Global Female Infertility Drugs Sales, 2023-2028
  4.3.3 By Type - Global Female Infertility Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Female Infertility Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Female Infertility Drugs Market Size, 2021 & 2028
  5.1.2 Fertility Clinics
  5.1.3 Hospitals
  5.1.4 Cryobanks
5.2 By Application - Global Female Infertility Drugs Revenue & Forecasts
  5.2.1 By Application - Global Female Infertility Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Female Infertility Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Female Infertility Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Female Infertility Drugs Sales & Forecasts
  5.3.1 By Application - Global Female Infertility Drugs Sales, 2017-2022
  5.3.2 By Application - Global Female Infertility Drugs Sales, 2023-2028
  5.3.3 By Application - Global Female Infertility Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Female Infertility Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Female Infertility Drugs Market Size, 2021 & 2028
6.2 By Region - Global Female Infertility Drugs Revenue & Forecasts
  6.2.1 By Region - Global Female Infertility Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Female Infertility Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Female Infertility Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Female Infertility Drugs Sales & Forecasts
  6.3.1 By Region - Global Female Infertility Drugs Sales, 2017-2022
  6.3.2 By Region - Global Female Infertility Drugs Sales, 2023-2028
  6.3.3 By Region - Global Female Infertility Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Female Infertility Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Female Infertility Drugs Sales, 2017-2028
  6.4.3 US Female Infertility Drugs Market Size, 2017-2028
  6.4.4 Canada Female Infertility Drugs Market Size, 2017-2028
  6.4.5 Mexico Female Infertility Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Female Infertility Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Female Infertility Drugs Sales, 2017-2028
  6.5.3 Germany Female Infertility Drugs Market Size, 2017-2028
  6.5.4 France Female Infertility Drugs Market Size, 2017-2028
  6.5.5 U.K. Female Infertility Drugs Market Size, 2017-2028
  6.5.6 Italy Female Infertility Drugs Market Size, 2017-2028
  6.5.7 Russia Female Infertility Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Female Infertility Drugs Market Size, 2017-2028
  6.5.9 Benelux Female Infertility Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Female Infertility Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Female Infertility Drugs Sales, 2017-2028
  6.6.3 China Female Infertility Drugs Market Size, 2017-2028
  6.6.4 Japan Female Infertility Drugs Market Size, 2017-2028
  6.6.5 South Korea Female Infertility Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Female Infertility Drugs Market Size, 2017-2028
  6.6.7 India Female Infertility Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Female Infertility Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Female Infertility Drugs Sales, 2017-2028
  6.7.3 Brazil Female Infertility Drugs Market Size, 2017-2028
  6.7.4 Argentina Female Infertility Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Female Infertility Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Female Infertility Drugs Sales, 2017-2028
  6.8.3 Turkey Female Infertility Drugs Market Size, 2017-2028
  6.8.4 Israel Female Infertility Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Female Infertility Drugs Market Size, 2017-2028
  6.8.6 UAE Female Infertility Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Allergan Plc
  7.1.1 Allergan Plc Corporate Summary
  7.1.2 Allergan Plc Business Overview
  7.1.3 Allergan Plc Female Infertility Drugs Major Product Offerings
  7.1.4 Allergan Plc Female Infertility Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 Allergan Plc Key News
7.2 Ferring BV
  7.2.1 Ferring BV Corporate Summary
  7.2.2 Ferring BV Business Overview
  7.2.3 Ferring BV Female Infertility Drugs Major Product Offerings
  7.2.4 Ferring BV Female Infertility Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 Ferring BV Key News
7.3 Merck KGaA
  7.3.1 Merck KGaA Corporate Summary
  7.3.2 Merck KGaA Business Overview
  7.3.3 Merck KGaA Female Infertility Drugs Major Product Offerings
  7.3.4 Merck KGaA Female Infertility Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 Merck KGaA Key News
7.4 Novartis AG
  7.4.1 Novartis AG Corporate Summary
  7.4.2 Novartis AG Business Overview
  7.4.3 Novartis AG Female Infertility Drugs Major Product Offerings
  7.4.4 Novartis AG Female Infertility Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Novartis AG Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi Female Infertility Drugs Major Product Offerings
  7.5.4 Sanofi Female Infertility Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 Sanofi Key News

8 GLOBAL FEMALE INFERTILITY DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Female Infertility Drugs Production Capacity, 2017-2028
8.2 Female Infertility Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Female Infertility Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 FEMALE INFERTILITY DRUGS SUPPLY CHAIN ANALYSIS

10.1 Female Infertility Drugs Industry Value Chain
10.2 Female Infertility Drugs Upstream Market
10.3 Female Infertility Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Female Infertility Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Female Infertility Drugs in Global Market
Table 2. Top Female Infertility Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Female Infertility Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Female Infertility Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Female Infertility Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Female Infertility Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Female Infertility Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Female Infertility Drugs Product Type
Table 9. List of Global Tier 1 Female Infertility Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Female Infertility Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Female Infertility Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Female Infertility Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Female Infertility Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Female Infertility Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Female Infertility Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Female Infertility Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Female Infertility Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Female Infertility Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Female Infertility Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Female Infertility Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Female Infertility Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Female Infertility Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Female Infertility Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Female Infertility Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Female Infertility Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Female Infertility Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Female Infertility Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Female Infertility Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Female Infertility Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Female Infertility Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Female Infertility Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Female Infertility Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Female Infertility Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Female Infertility Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Female Infertility Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Female Infertility Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Female Infertility Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Female Infertility Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Female Infertility Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Female Infertility Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Female Infertility Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Female Infertility Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Female Infertility Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Female Infertility Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Female Infertility Drugs Sales, (K Units), 2023-2028
Table 46. Allergan Plc Corporate Summary
Table 47. Allergan Plc Female Infertility Drugs Product Offerings
Table 48. Allergan Plc Female Infertility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Ferring BV Corporate Summary
Table 50. Ferring BV Female Infertility Drugs Product Offerings
Table 51. Ferring BV Female Infertility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Merck KGaA Corporate Summary
Table 53. Merck KGaA Female Infertility Drugs Product Offerings
Table 54. Merck KGaA Female Infertility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Novartis AG Corporate Summary
Table 56. Novartis AG Female Infertility Drugs Product Offerings
Table 57. Novartis AG Female Infertility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Sanofi Corporate Summary
Table 59. Sanofi Female Infertility Drugs Product Offerings
Table 60. Sanofi Female Infertility Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Female Infertility Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 62. Global Female Infertility Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Female Infertility Drugs Production by Region, 2017-2022 (K Units)
Table 64. Global Female Infertility Drugs Production by Region, 2023-2028 (K Units)
Table 65. Female Infertility Drugs Market Opportunities & Trends in Global Market
Table 66. Female Infertility Drugs Market Drivers in Global Market
Table 67. Female Infertility Drugs Market Restraints in Global Market
Table 68. Female Infertility Drugs Raw Materials
Table 69. Female Infertility Drugs Raw Materials Suppliers in Global Market
Table 70. Typical Female Infertility Drugs Downstream
Table 71. Female Infertility Drugs Downstream Clients in Global Market
Table 72. Female Infertility Drugs Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Female Infertility Drugs Segment by Type
Figure 2. Female Infertility Drugs Segment by Application
Figure 3. Global Female Infertility Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Female Infertility Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Female Infertility Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Female Infertility Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Female Infertility Drugs Revenue in 2021
Figure 9. By Type - Global Female Infertility Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Female Infertility Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Female Infertility Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Female Infertility Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Female Infertility Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Female Infertility Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Female Infertility Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Female Infertility Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Female Infertility Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Female Infertility Drugs Sales Market Share, 2017-2028
Figure 19. US Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Female Infertility Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Female Infertility Drugs Sales Market Share, 2017-2028
Figure 24. Germany Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Female Infertility Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Female Infertility Drugs Sales Market Share, 2017-2028
Figure 33. China Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Female Infertility Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Female Infertility Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Female Infertility Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Female Infertility Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Female Infertility Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Female Infertility Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Female Infertility Drugs by Region, 2021 VS 2028
Figure 50. Female Infertility Drugs Industry Value Chain
Figure 51. Marketing Channels


More Publications